Mammalian target of rapamycin inhibition.
Dutcher
Janice P
JP
Comprehensive Cancer Center, Our Lady of Mercy Medical Center, Bronx, New York 10466, USA. jpd4401@aol.com
D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D011494:Protein Kinases; D058570:TOR Serine-Threonine Kinases; D016896:Treatment Outcome
D004791:Enzyme Inhibitors; D011494:Protein Kinases; C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases